ArticleThe oncologist2022

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).

Kostandinos Sideras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.